Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
58m
Novavax’s Regulatory Setback and Mid-Term Underperformance: An Analyst’s Perspective
Analyst Eric Joseph of J.P. Morgan maintained a Sell rating on Novavax (NVAX – Research Report), retaining the price target of $9.00.
21m
COVID XEC is picking up steam in Canada. What we know about its symptoms and how to protect yourself
The XEC strain, first identified in Germany in June, made up an estimated 12.9 per cent of cases nation-wide last week, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Panel calls for 'reform'
One Direction singer dies
Fox News interview
NH justice indicted
100-yr-old capsule unveiled
Italy expands surrogacy ban
Sentenced for cartel bribery
Gets minimum 28 years
GA election rules blocked
Exotic cat caught in suburb
Cereal dyes protested
Disney to debut new pass
FDA halts Novavax trial
Abortion group sues Florida
New cervical cancer regimen
Ordered to pay $15 million
AL voter roll purge blocked
MI shooter drill settlement
US strikes Houthi targets
Synthetic nicotine pouches
To headline Atlanta rally
21K+ SUVs recalled
$425M military aid for UKR
Constitution copy auction
To cut up to 2,500 jobs
To settle US bribery probe
Feedback